Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 26, 2022 07:30 ET | Source: BioStem Technologies, Inc.

BioStem Promotes Michael Fortunato, CPA to Chief Financial Officer

POMPANO BEACH, FLORIDA., Oct. 26, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (“BioStem” or the “Company) (OTC PINK: BSEM), a leading regenerative medicine company focused on the development,...
October 10, 2022 07:30 ET | Source: BioStem Technologies, Inc.

BioStem to Present at the Dawson James Securities 2022 Small Cap Growth Conference

POMPANO BEACH, FLORIDA., Oct. 10, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC PINK: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
September 13, 2022 07:30 ET | Source: BioStem Technologies, Inc.

BioStem Announces Publication of a Standardized Method to Evaluate Growth Factor Elution from Placental Tissue Allografts

Standardized methodology demonstrates high presence of placental membrane growth factors in BioStem’s Vendaje® and Vendaje AC® tissue allografts POMPANO BEACH, FLORIDA., Sept. 13, 2022 (GLOBE...
September 08, 2022 07:30 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Strengthens its Board of Directors and Audit Committee with the Appointment of Accomplished Medtech Financial Leader Brandon Poe

POMPANO BEACH, FLORIDA., Sept. 08, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
August 22, 2022 16:01 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Reports Second Quarter 2022 Operating and Financial Results

Company to Host a Conference Call and Webcast on August 22, 2022, at 4:30 pm EDT POMPANO BEACH, FLORIDA., Aug. 22, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading...
August 16, 2022 07:30 ET | Source: BioStem Technologies, Inc.

BioStem Technologies to Host Second Quarter Financial Results and Corporate Update Conference Call on August 22nd

POMPANO BEACH, FLORIDA., Aug. 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
June 17, 2022 09:25 ET | Source: BioStem Technologies, Inc.

BioStem Technologies® CEO to Appear on the Benzinga All Access Show on June 17,2022

POMPANO BEACH, FLORIDA, June 17, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies® (OTC: BSEM), a leading, innovator focused on harnessing the natural properties of perinatal tissue in the development,...
May 16, 2022 12:25 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Reports March 31, 2022 Record Quarterly Financial Results

POMPANO BEACH, FLORIDA., May 16, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
April 01, 2022 10:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Inc. Reports December 31, 2021 Year End Financial Results

POMPANO BEACH, FLORIDA., April 01, 2022 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacture, and...
November 01, 2021 09:00 ET | Source: BioStem Technologies, Inc.

BioStem Technologies Announces Veterans Day Fundraiser to Support America's VetDogs®

Pompano Beach, Fl., Nov. 01, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. and its subsidiary Blue Tech Industries, Inc. (d/b/a BioStem Life Sciences), a Certified VOSB (Veteran-Owned Small...